Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 28, 2020

SELL
$62.63 - $80.22 $9.77 Million - $12.5 Million
-155,920 Closed
0 $0
Q4 2019

Feb 20, 2020

SELL
$61.62 - $67.78 $163,231 - $179,549
-2,649 Reduced 1.67%
155,920 $10.1 Million
Q3 2019

Oct 31, 2019

SELL
$62.51 - $69.0 $338,491 - $373,635
-5,415 Reduced 3.3%
158,569 $10.1 Million
Q2 2019

Aug 02, 2019

SELL
$61.87 - $69.38 $44,422 - $49,814
-718 Reduced 0.44%
163,984 $11.1 Million
Q1 2019

Apr 24, 2019

BUY
$62.53 - $70.05 $404,819 - $453,503
6,474 Added 4.09%
164,702 $10.7 Million
Q4 2018

Jan 24, 2019

SELL
$60.54 - $79.0 $702,808 - $917,111
-11,609 Reduced 6.84%
158,228 $9.9 Million
Q3 2018

Oct 26, 2018

SELL
$71.28 - $78.92 $271,291 - $300,369
-3,806 Reduced 2.19%
169,837 $13.1 Million
Q2 2018

Jul 26, 2018

SELL
$64.88 - $75.68 $388,696 - $453,398
-5,991 Reduced 3.34%
173,643 $12.3 Million
Q1 2018

Apr 25, 2018

SELL
$72.84 - $88.8 $329,455 - $401,642
-4,523 Reduced 2.46%
179,634 $13.5 Million
Q4 2017

Jan 24, 2018

SELL
$71.15 - $83.52 $1.3 Million - $1.52 Million
-18,248 Reduced 9.02%
184,157 $13.2 Million
Q3 2017

Oct 30, 2017

BUY
$72.11 - $85.47 $14.6 Million - $17.3 Million
202,405
202,405 $16.4 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track North Point Portfolio Managers Corp Portfolio

Follow North Point Portfolio Managers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Point Portfolio Managers Corp, based on Form 13F filings with the SEC.

News

Stay updated on North Point Portfolio Managers Corp with notifications on news.